These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27088112)

  • 1. Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.
    Comella CL; Fox SH; Bhatia KP; Perlmutter JS; Jinnah HA; Zurowski M; McDonald WM; Marsh L; Rosen AR; Waliczek T; Wright LJ; Galpern WR; Stebbins GT
    Mov Disord Clin Pract; 2015 Jun; 2(2):135-141. PubMed ID: 27088112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric testing of the comprehensive cervical dystonia rating scale.
    Comella CL; Perlmutter JS; Jinnah HA; Waliczek TA; Rosen AR; Galpern WR; Adler CA; Barbano RL; Factor SA; Goetz CG; Jankovic J; Reich SG; Rodriguez RL; Severt WL; Zurowski M; Fox SH; Stebbins GT
    Mov Disord; 2016 Apr; 31(4):563-9. PubMed ID: 26971359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
    Kaji R; Osawa M; Yanagisawa N
    Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
    Tarsy D
    Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport
    Simonetta-Moreau M; Picaut P; Volteau M; Poewe W
    Eur J Neurol; 2019 Jun; 26(6):943-e65. PubMed ID: 30168896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content overlap of 91 dystonia symptoms among the seven most commonly used cervical dystonia scales.
    Chrobak AA; Rusinek J; Dec-Ćwiek M; Porębska K; Siwek M
    Neurol Sci; 2024 Apr; 45(4):1507-1514. PubMed ID: 37910323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data.
    Jen MH; Kurth H; Iheanacho I; Dinet J; Gabriel S; Wasiak R; Jost WH
    J Med Econ; 2014 Nov; 17(11):803-9. PubMed ID: 25155368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
    Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
    Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?
    Cotton AC; Scorr L; McDonald W; Comella C; Perlmutter JS; Goetz CG; Jankovic J; Marsh L; Factor S; Jinnah HA
    Mov Disord Clin Pract; 2023 Sep; 10(9):1399-1403. PubMed ID: 37772296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Disease-Specific Oromandibular Dystonia Rating Scale (OMDRS).
    Yoshida K
    Front Neurol; 2020; 11():583177. PubMed ID: 33224096
    [No Abstract]   [Full Text] [Related]  

  • 12. It's tricky: Rating alleviating maneuvers in cervical dystonia.
    Cisneros E; Stebbins GT; Chen Q; Vu JP; Benadof CN; Zhang Z; Barbano RL; Fox SH; Goetz CG; Jankovic J; Jinnah HA; Perlmutter JS; Adler CH; Factor SA; Reich SG; Rodriguez R; Severt LL; Stover NP; Berman BD; Comella CL; Peterson DA
    J Neurol Sci; 2020 Dec; 419():117205. PubMed ID: 33160248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
    Espay AJ; Trosch R; Suarez G; Johnson J; Marchese D; Comella C
    Parkinsonism Relat Disord; 2018 Jul; 52():94-97. PubMed ID: 29530726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).
    Cano SJ; Warner TT; Linacre JM; Bhatia KP; Thompson AJ; Fitzpatrick R; Hobart JC
    Neurology; 2004 Nov; 63(9):1629-33. PubMed ID: 15534247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of DNMSQuest as a Screening Tool for Mood Disorders in Cervical Dystonia.
    Rafee S; Ndukwe I; O'Riordan S; Hutchinson M
    Mov Disord Clin Pract; 2021 Aug; 8(6):925-931. PubMed ID: 34405100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Foot Progression Angle Kinematics in Cervical Dystonia Improved After Osteopathic Manipulative Medicine: A Prospective Case Series.
    Mancini J; Oliff Z; Abu-Sbaih R; Simone J; LaRosa A; Mody S; Li TS; Leder A
    Cureus; 2022 Jun; 14(6):e26459. PubMed ID: 35915700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study.
    Dashtipour K; Mari Z; Jankovic J; Adler CH; Schwartz M; Brin MF
    J Neurol Sci; 2019 Oct; 405():116413. PubMed ID: 31494402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE.
    Agarwal P; Barbano R; Moore H; Schwartz M; Zuzek A; Sadeghi M; Patel A
    Front Neurol; 2022; 13():914486. PubMed ID: 35847221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
    Comella CL; Stebbins GT; Goetz CG; Chmura TA; Bressman SB; Lang AE
    Mov Disord; 1997 Jul; 12(4):570-5. PubMed ID: 9251076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.
    Jost WH; Hefter H; Stenner A; Reichel G
    J Neural Transm (Vienna); 2013 Mar; 120(3):487-96. PubMed ID: 22899277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.